VRXA
Veraxa Biotech AG
1.20$
-4.8%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| – | – | -42,270.7% | |
| – | – | 8,420.4% | |
| – | – | 224,807.1% | |
| – | – | 5,029.0% | |
| – | – | 1,866.2% | |
| – | – | 3,566.0% | |
| – | – | 28,134.8% | |
| – | – | -16,002.1% | |
| – | – | -44,136.9% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.